September 28, 2016
(STAT News) – The Food and Drug Administration on Wednesday approved the first so-called artificial pancreas, an out-of-body device expected to lift the burden for some diabetics on the daily grind they must go through to keep their blood sugar levels stable. It will soon be available for patients with type 1 diabetes who are over age 14. The device, which looks like a smartphone and was developed by Medtronic, is designed to automatically monitor and administer insulin for type 1 diabetes patients, for whom the pancreas’s ability to provide insulin naturally is impaired.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.